Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.95 USD | +0.25% | -5.05% | +12.54% |
Evolution of the average Target Price on Aldeyra Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aldeyra Therapeutics, Inc.
Oppenheimer | |
Citigroup | |
HC Wainwright | |
Berenberg Bank | |
SVB Leerink | |
Alliance Global Partners |
EPS Revisions
- Stock Market
- Equities
- ALDX Stock
- Consensus Aldeyra Therapeutics, Inc.